SEATTLE — Seattle Children's Research Institute and Washington State University have just entered a new partnership. The new pilot grant program is a collaboration both organizations hope will improve ...

ABUSED, homeless and just one pound coin in her pocket – this was the hand that life had dealt 15-year-old Georgina Tang. She ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

As fitness becomes more than just a lifestyle trend, Dubai is fast emerging as one of the world’s most forward-thinking ...